MedPath

The comparison of Aripiprazole and Quetiapine augmentation between Selective Serotonin reuptake inhibitors in refractory obsessive-compulsive disorder.

Not Applicable
Conditions
obsessive- compulsive disorder.
Obsessive-compulsive disorder
Registration Number
IRCT2013040612905N1
Lead Sponsor
Vice chancellor for research, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Age between 18-65 years?Patients with a diagnosis of OCD?Patients who are non-responsive to primary treatment confirmed by a Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score more than 16.
The exclusion criteria:Patients with current or previous diagnosis of psychosis? Mental retardation?Substance abuse? Psychiatric disorders due to organic diseases.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Obsession sevirity. Timepoint: before intervention\ week4\week8\ week12. Method of measurement: score of Y-BOCS test.;General improvement. Timepoint: before intervention\ week 4\ week 8\ week12. Method of measurement: score of CGI test.;Depression. Timepoint: before intervention\ week 12. Method of measurement: Hamilton Depression Rating Scale.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath